- Trxade
Group reported record revenues of over $1.9 million in its second quarter
filing, as well as increased operating income and net income obtained
through its acquisition of independent pharmacy services
- Trxade
Group is a pharmaceutical services network dedicated to helping
independent pharmacies remain competitive through its web-based purchasing
platform, data analytics and delivery services
- Trxade
also reported a year-over-year increase in operating income, from $31,446
to $132,705, and net income, from $20,513 to $57,981
- Gross
profits rose to more than $1.1 million, with a gross margin of 60.7
percent offset by increased cost of sales from one of the company’s
acquisitions
Florida-based Trxade Group Inc. (OTCQB: TRXD), a pharmaceutical services
network that brings the buyers and sellers of pharmaceutical products and
services together in its own community of trust, technology and transparency,
reported ongoing record revenue growth as well as an increase in gross profits
and independent pharmacy subscribers as part of its second-quarter financial
statement.
Trxade reported that its revenues for the three months ended
June 30 were over $1.9 million, marking an increase of 129 percent over the
year-ago quarter’s $837,688. It also marked a 27 percent sequential increase
over the first quarter ended March 31, according to a news release issued July
29 (http://ibn.fm/1uFir).
Operating income rose during the quarter to $132,705, versus
$31,446 a year ago. Net income increased to $57,981 from last year’s second
quarter report of $20,513. The gains in revenue and income were primarily
attributed to the acquisition of Community Specialty Pharmacy LLC and an
increase of fee income generated by the company’s web-based
supplier-to-pharmacy trading platform.
Gross profit for the quarter was over $1.1 million, which
created a gross margin of 60.7 percent for the three-month period, as compared
to $837,688 and 100 percent respectively for the second quarter of the previous
year. The margin decrease was attributable to greater revenues mixed with
higher costs of sales from its acquisition of independent pharmacy services.
“We made excellent progress executing against our key
strategic priorities in our Delivmeds.com program, our B2C commercial efforts
and our proprietary B2B trading platform www.Trxade.com… enabling us to experience top and bottom
line growth,” Trxade Group Chairman and CEO Suren Ajjarapu stated in a news
release. “Accordingly, I am optimistic that our new product lines will generate
profitability as increasing pharmaceutical prices drive independent pharmacies,
payors and consumers to be more aggressive in sourcing medication.”
Trxade Group’s resources, which include software that links
a member-pharmacist network, a platform for buying medications at competitive
prices and services for storing and delivery pharmaceuticals, are designed to
empower independently owned pharmacies and help them manage their inventories
and operations through data analysis.
For more information, visit the company’s website at www.TrxadeGroup.com
NOTE TO INVESTORS: The latest news and updates
relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php